Zyloric [treatment of gout]

Zyloric indicated in the treatment of gout (see also ALLOPURINOL - WF/M/PL/012). It is used to reduce urate concentrations in body fluids and or urine to prevent or reverse the deposition of urate/uric acid. It is indicated for the main clinical manifestations of urate/uric deposition. These are gouty arthritis, skin tophi and or renal involvement through crystal deposition or stone formation. Supplied in creamy white tablet containing either 100mg or 300mg allopurinol.

Folder 1 includes product information via brochures and booklets; marketing memorandum no 430; study booklet; GACT text issued 1978.

Folder 2 includes product information "The logical answer"- multi media data file with colour slides.

Folder 3 includes product information via "Dear Dir/Dr." letters and colour transparencies and black and white negatives of calcium stones 1983.

Folder 4 includes product information via abstracts.

Folder 5 includes product information brochures, sheet advertising and pamphlets- undated material.

Folder 6 includes overseas material including German, French; Arabic- product information via brochures.

Folder 7 includes overseas product information via brochures and pamphlets.

Folder 8 includes product information "la goutte" A Ryckewaert et D. Kuntz; book.

Folder 9 includes U.K. dated material bundled in years 1968, 1967 and 1966. Product information includes symposium, brochures and advertising directed at the consumer.

Folder 10 includes product information number 4 prepared by the Marketing Division March 1969.

Folder 11 includes U.K. dated material bundled in years 1970 and 1969. Product information includes brochures and advertising directed at the consumer.

Folder 12 includes U.K. dated material bundled in years 1971 and 1972. Product information includes brochures and advertising directed at the consumer.

Folder 13 includes U.K .dated material bundled in year 1973. Product information includes brochures, "Zyloric a better form of therapy" packaging and advertising.

Folder 14 includes U.K. dated material bundled in year 1974. Product information includes brochures.

Folder 15 includes U.K .dated material bundled in year 1975. Product information includes brochures and advertising directed at the consumer.

Folder 16 includes U.K. dated material bundled in year 1976. Product information includes brochures and advertising directed at the consumer.

Folder 17 includes U.K. dated material bundled in year 1977. Product information includes brochures on arthritis and advertising, "The Purine Revolution"information on a medical film presented by Wellcome.

Folder 18 includes U.K. dated material bundled in year 1978. Product information includes brochures and advertising including the gouty arthritis newsletter- medical publicity.

Folder 19 includes U.K. dated material bundled in year 1979. Product information includes brochures on treatment of uric acid; kidney stones; gout and the gouty arthritis newsletter- medical publicity.

Folder 20 includes U.K. dated material bundled in year 1980. Product information includes "Uric acid disorders and their treatment"; "About your gouty arthritis"; "Gouty Arthritis in general practice";The Treatment of Gouty Arthritis" and "Diagnosis of Gouty Arthritis" brochures.

Folder 21 includes U.K. dated material bundled in year 1981. Product information includes brochures "The treatment of uric acid related disorders"; "looking into Calcium Stones"and advertising pamphlets directed at the consumer.

Folder 22 includes U.K. dated material bundled in year 1982 and 1983. Product information includes brochures "The treatment of uric acid related disorders" and advertising directed at the consumer.

Folder 23 includes U.K .dated material bundled in year 1984, 1985 and 1986. Product information includes brochures "The treatment of uric acid related disorders"and advertising directed at the consumer and medical publicity.

Folder 24 includes U.K. dated material - one 1988 calender of "Classic British Engravings from The Wellcome Foundation Ltd". Zyloric -300 with prescribing information on the last page.

c.1960-1988

24 Items

Copyright assigned to the Wellcome Trust